|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/04 | (2006.01) |
| A61K 39/36 | (2006.01) | ||
| C07K 7/04 | (2006.01) | ||
| A61P 37/08 | (2006.01) |
| (11) | Number of the document | 2153841 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09251252.4 |
| Date of filing the European patent application | 2009-05-01 | |
| (97) | Date of publication of the European application | 2010-02-17 |
| (45) | Date of publication and mention of the grant of the patent | 2011-12-14 |
| (46) | Date of publication of the claims translation | 2012-05-25 |
| (30) | Number | Date | Country code |
| 0814986 | 2008-08-15 | GB | |
| 0815218 | 2008-08-20 | GB |
| (72) |
Larche, Mark, CA
Hafner, Roderick Peter, GB
Laidler, Paul, GB
|
| (73) |
Circassia Limited,
Magdalen Centre The Oxford Science Park, Oxford OX4 4GA,
GB
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Vakcina, apimanti AMB A 1 peptidus, skirta naudoti alergijos ambrozijai gydyme |
| Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy |
| Payment date | Validity (years) | Amount | |
| 2016-04-19 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2017-05-01 |